Mitsubishi Chemical Group Corporation

For FY2025, sales revenue was JPY 3,704 billion, down JPY 343.6 billion year on year. Core operating income was JPY 225 billion, down JPY 3.8 billion year on year; operating income was JPY 3.1 billion; income before taxes was JPY 0.7 billion; and net income attributable to owners of the parent was JPY 11.8 billion, down JPY 33.2 billion year on year. Special items were negative JPY 194.9 billion, including JPY 30.3 billion of Soarnol-related impairment losses and other restructuring charges. On cash flow, operating cash flow was an inflow of JPY 436.3 billion, CapEx cash flow was an outflow of JPY 292.1 billion, and free cash flow was positive JPY 560.8 billion; net interest-bearing debt fell to JPY 387.5 billion and net D/E improved to 0.83 from 1.06. For FY2026, management guides to sales revenue of JPY 3.8 trillion, core operating income of JPY 305 billion, operating income of JPY 300 billion, income before taxes of JPY 270 billion, net income from continuing operations of JPY 200 billion, and net income attributable to owners of the parent of JPY 127 billion. The company also guided to a JPY 32 annual dividend (JPY 16 interim and JPY 16 year-end).

CEO Manabu Chikumoto framed FY2025 as a year of painful but necessary cleanup, saying the company “fully carry out what must be done” through decisive structural reforms and that the weak results reflected that push. He apologized to shareholders for the shortfall and emphasized stricter oversight on investment execution after the Soarnol impairment. His tone was cautious but optimistic on FY2026, pointing to Specialty Materials growth, new capacity in Europe, semiconductor and battery-related demand, carbon fiber opportunities including robotaxis, and aerospace-related business.

CFO Minoru Kida said FY2025 was pressured by weak MMA and Basic Materials/Polymers markets, but Specialty Materials and industrial gases held up well. He broke out FY2025 sales revenue of JPY 3,704 billion, core operating income of JPY 225 billion, special items of negative JPY 194.9 billion, and net debt of JPY 387.5 billion, and noted that the net D/E ratio improved to 0.83. For FY2026, he guided to JPY 305 billion of core operating income and explained that the increase should come from higher specialty materials volumes, cost reductions, MMA market recovery, and industrial gas strength; he also quantified a JPY 48 billion benefit from disciplined-business measures, a possible JPY 18 billion downside from Middle East tensions, and a dividend plan of JPY 32 per share.

Analysts focused heavily on the Middle East exposure, asking how much of the JPY 18 billion downside was driven by raw materials, inventory revaluation, or supply disruptions. Management said the bigger risk was supply-chain disruption and lost volume rather than pure naphtha cost pass-through, and said it does not expect a major production shortage, though it is monitoring the situation closely. Questions also centered on the FY2026 Specialty Materials uplift and the robotaxi carbon-composite business; management said shipments could triple or quadruple next year but declined to give exact shipment numbers due to contractual limits. On MMA, management said the FY2026 downside from the Middle East is mainly a volume issue, not a spread issue, and that April looked slightly positive but was too early to draw firm conclusions.